Breast

Papers
(The H4-Index of Breast is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial Board2483
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients238
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines198
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients176
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes132
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer126
P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling104
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients92
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)88
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study76
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions72
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?71
Editorial Board67
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer60
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS54
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT47
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)47
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction45
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?45
No association between breast pain and breast cancer44
Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures43
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer43
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?42
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery42
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience40
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY39
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective38
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis37
A SYSTEMATIC REVIEW OF SAFETY AND IMPACT ON QUALITY OF LIFE WITH USE OF VAGINAL OESTROGENS DURING ENDOCRINE THERAPY FOR HORMONE RECEPTOR POSITIVE BREAST CANCER37
Increasing incidence of breast cancer in young women over time34
Impact of stereotactic body radiation therapy on systemic therapeutic line change in oligometastatic breast cancer34
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study33
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology33
0.11318397521973